Literature DB >> 24218498

Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis.

Stephanie M Hamilton1, Clifford R Bayer, Dennis L Stevens, Amy E Bryant.   

Abstract

BACKGROUND: Epidemiologic evidence suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) contribute to more severe group A streptococcal (GAS) infections, yet a beneficial role for NSAIDs has been demonstrated in other experimental bacterial infections.
METHODS: Nonselective (ketorolac tromethamine, ibuprofen, indomethacin), COX-1-selective (SC-560), or COX-2-selective (SC-236) NSAIDs ± antibiotics (penicillin, clindamycin) were given to mice challenged intramuscularly with M-type 3 GAS and disease course was followed for 14 days. RESULTS. All nonselective NSAIDs significantly accelerated mortality and reduced antibiotic efficacy; COX-selective NSAIDs had no significant effects.
CONCLUSIONS: Use of nonselective NSAIDs, either alone or as adjuncts to antibiotic therapy, for GAS soft tissue infection may contribute to worse outcomes.

Entities:  

Keywords:  NSAIDs; Streptococcus pyogenes; myonecrosis

Mesh:

Substances:

Year:  2013        PMID: 24218498      PMCID: PMC3982845          DOI: 10.1093/infdis/jit594

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

Review 1.  Nonsteroidal antiinflammatory drugs--differences and similarities.

Authors:  P M Brooks; R O Day
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

2.  Altered IL-4 mRNA stability correlates with Th1 and Th2 bias and susceptibility to hypersensitivity pneumonitis in two inbred strains of mice.

Authors:  Noah S Butler; Martha M Monick; Timur O Yarovinsky; Linda S Powers; Gary W Hunninghake
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

3.  Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice.

Authors:  Tzu-Chieh Weng; Chi-Chung Chen; Han-Siong Toh; Hung-Jen Tang
Journal:  J Microbiol Immunol Infect       Date:  2011-06-22       Impact factor: 4.399

4.  Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella.

Authors:  S M Lesko; K L O'Brien; B Schwartz; R Vezina; A A Mitchell
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

5.  The COX-2 pathway is essential during early stages of skeletal muscle regeneration.

Authors:  Brenda A Bondesen; Stephen T Mills; Kristy M Kegley; Grace K Pavlath
Journal:  Am J Physiol Cell Physiol       Date:  2004-04-14       Impact factor: 4.249

6.  Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

Authors:  Elisabeth Ott; Nancy A Nussmeier; Peter C Duke; Robert O Feneck; R Peter Alston; Michael C Snabes; Richard C Hubbard; Ping H Hsu; Lawrence J Saidman; Dennis T Mangano
Journal:  J Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 5.209

Review 7.  Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus.

Authors:  David M Aronoff; Karen C Bloch
Journal:  Medicine (Baltimore)       Date:  2003-07       Impact factor: 1.889

8.  The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

Authors:  D L Stevens; A E Gibbons; R Bergstrom; V Winn
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

9.  Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect.

Authors:  D L Stevens; S Yan; A E Bryant
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  10 in total

1.  Interactions between nociceptor sensory neurons and microbial pathogens in pain.

Authors:  Larissa Staurengo-Ferrari; Liwen Deng; Isaac M Chiu
Journal:  Pain       Date:  2022-11-01       Impact factor: 7.926

Review 2.  The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections.

Authors:  Amy E Bryant; Clifford R Bayer; Michael J Aldape; Dennis L Stevens
Journal:  Curr Opin Infect Dis       Date:  2015-06       Impact factor: 4.915

3.  Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314.

Authors:  Kimbria J Blake; Pankaj Baral; Tiphaine Voisin; Ashira Lubkin; Felipe Almeida Pinho-Ribeiro; Kelsey L Adams; David P Roberson; Yuxin C Ma; Michael Otto; Clifford J Woolf; Victor J Torres; Isaac M Chiu
Journal:  Nat Commun       Date:  2018-01-02       Impact factor: 14.919

4.  Effects of delayed NSAID administration after experimental eccentric contraction injury - A cellular and proteomics study.

Authors:  Amy E Bryant; Michael J Aldape; Clifford R Bayer; Eva J Katahira; Laura Bond; Carrie D Nicora; Thomas L Fillmore; Therese R W Clauss; Thomas O Metz; Bobbie-Jo Webb-Robertson; Dennis L Stevens
Journal:  PLoS One       Date:  2017-02-28       Impact factor: 3.240

Review 5.  Management of Infectious Emergencies for the Inpatient Dermatologist.

Authors:  Tulsi Patel; Krystina Quow; Adela R Cardones
Journal:  Curr Dermatol Rep       Date:  2021-10-06

6.  Prostaglandin E₂ constrains systemic inflammation through an innate lymphoid cell-IL-22 axis.

Authors:  Rodger Duffin; Richard A O'Connor; Siobhan Crittenden; Thorsten Forster; Cunjing Yu; Xiaozhong Zheng; Danielle Smyth; Calum T Robb; Fiona Rossi; Christos Skouras; Shaohui Tang; James Richards; Antonella Pellicoro; Richard B Weller; Richard M Breyer; Damian J Mole; John P Iredale; Stephen M Anderton; Shuh Narumiya; Rick M Maizels; Peter Ghazal; Sarah E Howie; Adriano G Rossi; Chengcan Yao
Journal:  Science       Date:  2016-03-18       Impact factor: 47.728

7.  Opportunistic Invasive Infection by Group A Streptococcus During Anti-Interleukin-6 Immunotherapy.

Authors:  Shyra Wilde; Katherine L Olivares; Victor Nizet; Hal M Hoffman; Suhas Radhakrishna; Christopher N LaRock
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

Review 8.  Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection.

Authors:  Joëlle Micallef; Thomas Soeiro; Annie-Pierre Jonville-Béra
Journal:  Therapie       Date:  2020-05-07       Impact factor: 2.070

Review 9.  Effect of non-steroidal anti-inflammatory drugs on post-surgical complications against the backdrop of the opioid crisis.

Authors:  Hannah Zhao-Fleming; Audrey Hand; Kelly Zhang; Robert Polak; Armand Northcut; Daron Jacob; Sharmila Dissanaike; Kendra P Rumbaugh
Journal:  Burns Trauma       Date:  2018-09-13

Review 10.  Streptococcal toxic shock syndrome in the intensive care unit.

Authors:  Marylin Schmitz; Xavier Roux; Benedikt Huttner; Jérôme Pugin
Journal:  Ann Intensive Care       Date:  2018-09-17       Impact factor: 6.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.